Biomerieux (France) Today
BIM Stock | EUR 98.70 0.15 0.15% |
Performance1 of 100
| Odds Of DistressLess than 9
|
Biomerieux is trading at 98.70 as of the 7th of May 2024, a -0.15 percent decrease since the beginning of the trading day. The stock's open price was 98.85. Biomerieux has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for Biomerieux SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 13th of May 2023 and ending today, the 7th of May 2024. Click here to learn more.
bioMrieux S.A. provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company was formerly known as B-D Mrieux. bioMrieux S.A. was founded in 1963 and is based in Marcy lEtoile, France. The company has 118.37 M outstanding shares. More on Biomerieux SA
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biomerieux Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biomerieux's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biomerieux or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business Concentration | Diagnostics & Research, Healthcare (View all Sectors) |
Biomerieux SA (BIM) is traded on Euronext Paris in France and employs 12,084 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 11.04 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biomerieux's market, we take the total number of its shares issued and multiply it by Biomerieux's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biomerieux SA operates under Healthcare sector and is part of Diagnostics & Research industry. The entity has 118.37 M outstanding shares.
Biomerieux SA has accumulated about 280.1 M in cash with 811.1 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.38.
Check Biomerieux Probability Of Bankruptcy
Ownership AllocationBiomerieux holds a total of 118.37 Million outstanding shares. Biomerieux SA shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 64.28 percent of Biomerieux SA outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biomerieux Ownership Details
Biomerieux SA Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Biomerieux market risk premium is the additional return an investor will receive from holding Biomerieux long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biomerieux. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Biomerieux's alpha and beta are two of the key measurements used to evaluate Biomerieux's performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 1.09 | |||
Standard Deviation | 1.69 | |||
Variance | 2.87 | |||
Risk Adjusted Performance | 0.0063 |
Biomerieux Stock Against Markets
Picking the right benchmark for Biomerieux stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Biomerieux stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Biomerieux is critical whether you are bullish or bearish towards Biomerieux SA at a given time. Please also check how Biomerieux's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biomerieux without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
All Next | Launch Module |
Biomerieux Corporate Management
Elected by the shareholders, the Biomerieux's board of directors comprises two types of representatives: Biomerieux inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biomerieux. The board's role is to monitor Biomerieux's management team and ensure that shareholders' interests are well served. Biomerieux's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biomerieux's outside directors are responsible for providing unbiased perspectives on the board's policies.
Frederic Beseme | Head CSR | Profile | |
Guillaume Bouhours | Ex CFO | Profile | |
Pierre Boulud | Chief Operations | Profile | |
Franois Lacoste | Ex RD | Profile | |
Mark Miller | Ex Affairs | Profile | |
Alexandre Merieux | Chairman CEO | Profile | |
Valerie Leylde | Communications HR | Profile |
How to buy Biomerieux Stock?
Before investing in Biomerieux, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Biomerieux. To buy Biomerieux stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Biomerieux. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Biomerieux stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Biomerieux SA stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Biomerieux SA stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Biomerieux SA, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Biomerieux SA?
The danger of trading Biomerieux SA is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biomerieux is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biomerieux. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biomerieux SA is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerieux SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Biomerieux Stock analysis
When running Biomerieux's price analysis, check to measure Biomerieux's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerieux is operating at the current time. Most of Biomerieux's value examination focuses on studying past and present price action to predict the probability of Biomerieux's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerieux's price. Additionally, you may evaluate how the addition of Biomerieux to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
CEOs Directory Screen CEOs from public companies around the world | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |